An Overview of Chronic Heart

Vyas Gitesh vinod; Shital Ramrao Golde; Rawat S S; Sunil S Jaybhayer; Komal B J aiswal; Pallavi R Garkhede

An Overview of Chronic Heart

Authors: Vyas Gitesh vinod, Shital Ramrao Golde, Rawat S S, Sunil S Jaybhayer, Komal B J aiswal, Pallavi R Garkhede

Unique Paper ID: 160487
Volume: 10
Issue: 1
PageNo: 699-706

Keywords: ACE inhibitors Aldosterone antagonists angiotensin receptor antagonist beta blockers chronic Heart Failure digoxin neprilysin inhibitors sartans

Abstract:
Chronic heart failure (CHF) remains the only disease with an increasing hospitalization burden and an ongoing drain on health care expenditures. The prevalence of CHF increases with advancing life span, with diastolic heart failure predominating in the elderly population. Primary prevention of coronary artery disease and risk factor management via aggressive blood pressure control are central in preventing new occurrences of left ventricular dysfunction. Optimal therapy for CHF involves identification and correction of potentially reversible precipitants, target-dose titration of medical therapy, and management of hospitalizations for decompensation. The etiological phenotype, absolute decrease in left ventricular ejection fraction and a widening of QRS duration on electrocardiography, is commonly used to identify patients at increased risk of progression of heart failure and sudden death who may benefit from prophylactic implantable cardioverter-defibrillator placement with or without cardiac resynchronization therapy. Chronic heart failure (CHF) is a progressive syndrome that results in a poor quality of life for the patient and places an economic burden on the health care system. Despite advances in the control of cardiovascular diseases such as myocardial infarction (MI), the incidence and prevalence of CHF continue to increase. An accurate estimate of disease burden is difficult to gather because of the vast number of patients with asymptomatic left ventricular (LV) dysfunction. As the population ages, there is an epidemiological shift toward a greater prevalence of clinical heart failure with preserved LV function, the so- called stiff-heart syndrome. In fact, heart failure with preserved systolic function may account for up to two-thirds of cases in patients older than 70 years.2 Regardless of age, the lifetime risk of developing heart failure is approximately 20% for all patients older than 40 years.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 10
Issue: 1
PageNo: 699-706

An Overview of Chronic Heart

Available:https://ijirt.org/Article?manuscript=160487

04 Jun, 2023

An complete Review on Alzheimerâ€™s Disease

03 Jun, 2023

AN OVERVIEW OF CONTRACT RESEARCH ORGANISATION

27 May, 2023

To Study formulation and evaluation of herbal hair oil

19 Feb, 2023

A complete review on Immunosuppressants Drugs

29 Dec, 2022

Stem Cell Complete Overview on Past, Present, future

25 Dec, 2022

An complete study of thyroid disease and itâ€™s control in India

24 Dec, 2022

An Complete overview on Type 2 Diabetes Mellitus

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry